[EN] ISOTOPICALLY ENRICHED ARYLSULFONAMIDE CCR3 ANTAGONISTS<br/>[FR] ANTAGONISTES DE CCR3 DE TYPE ARYLSULFONAMIDES ENRICHIS EN ISOTOPES
申请人:AXIKIN PHARMACEUTICALS INC
公开号:WO2014039748A1
公开(公告)日:2014-03-13
Provided herein are isotopically enriched arylsulfonamides, for example, of Formula I, that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disease, disorder, or condition.